Phase I clinical and pharmacokinetic trial of the cyclin-dependent kinase inhibitor flavopiridol.
Thomas JP, Tutsch KD, Cleary JF, Bailey HH, Arzoomanian R, Alberti D, Simon K, Feierabend C, Binger K, Marnocha R, Dresen A, Wilding G.
Thomas JP, et al. Among authors: tutsch kd.
Cancer Chemother Pharmacol. 2002 Dec;50(6):465-72. doi: 10.1007/s00280-002-0527-2. Epub 2002 Oct 2.
Cancer Chemother Pharmacol. 2002.
PMID: 12451473
Clinical Trial.